Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor

Dendritic cells are important in initiating immune responses; therefore, a range of dendritic cell–based approaches have been established to induce immune response against cancer cells. However, the presence of immunosuppressive mediators such as adenosine in the tumor microenvironment reduces the e...

Full description

Bibliographic Details
Main Authors: Samaneh Arab, Nasim Kheshtchin, Maryam Ajami, Mahbubeh Ashurpoor, Aida Safvati, Afshin Namdar, Reza Mirzaei, Neda Mousavi Niri, Farhad Jadidi-Niaragh, Mohammad Hossein Ghahremani, Jamshid Hadjati
Format: Article
Language:English
Published: IOS Press 2017-03-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317695021